IGM Biosciences Appoints M. Kathleen Behrens to its Board of Directors
January 31, 2019 at 11:30 am
IGM Biosciences, Inc. (IGM) announced the appointment of M. Kathleen Behrens, Ph.D., to its Board of Directors. Dr. Behrens has been a pioneer in the biotech industry throughout her career, beginning as an equity research analyst at Robertson Stephens & Co. Dr. Behrens currently serves as the Chair of the Board of Directors of Sarepta Therapeutics, Inc. and has been a member of its Board since 2009.